Aleta Biotherapeutics is pioneering a transformation of cancer treatment by enabling CAR-T cell cancer therapies to work more effectively
Aleta Biotherapeutics is pioneering a transformation of cancer treatment by enabling CAR-T cell cancer therapies to work more effectively. The Company’s unique portfolio of multi-antigen CAR-T Engagers (CTEs) are simple, potent biologic therapies designed to transform the expression of cancer tumor cells to match CAR-T cell therapies circulating in patient blood.